Rafael Díaz

77.4k citations
130 papers · 18.4k indexed · 7 hit papers · h-index 45

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Cardiac Arrhythmias and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Acute Myocardial Infarction Research
    • Heart Failure Treatment and Management

Papers in

    • Acute Myocardial Infarction Research 27
    • Antiplatelet Therapy and Cardiovascular Diseases 26
    • Atrial Fibrillation Management and Outcomes 20
    • Heart Failure Treatment and Management 17
    • Cardiovascular Function and Risk Factors 16

Rafael Díaz

127 papers receiving 17.8k citations

Hit Papers

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial 2022 · 439 citations
43920062026201220192.5k5.0k7.5k

Peers

Rafael Díaz
Comparison fields: 5 of 169
  • Internal Medicine 4.1k
  • Cardiology and Cardiovascular Medicine 12.7k
  • Endocrinology, Diabetes and Metabolism 3.9k
  • Surgery 3.1k
  • Hematology 745
Replace Renato D. Lópes with:
Renato D. Lópes United States
Janice Pogue Canada
Benjamin M. Scirica United States
Brian F. Gage United States
Andrzej Budaj Poland
Basil S. Lewis Israel
Felicita Andreotti Italy
Shinya Goto Japan
Shaun G. Goodman Canada
Dominick J. Angiolillo United States
Rafael Díaz relative to Renato D. Lópes United States Renato D. Lópes's profile →
Citations per field
00.5×1.5×2.0×
Renato D. Lópes · 1×
Citations per year

Countries citing papers authored by Rafael Díaz

Since Specialization
Citations

This map shows the geographic impact of Rafael Díaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Díaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Díaz more than expected).

Fields of papers citing papers by Rafael Díaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Díaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Díaz. The network helps show where Rafael Díaz may publish in the future.

Co-authors

The 25 scholars most cited alongside Rafael Díaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rafael Díaz Line = papers co-authored together Rafael Díaz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20241
3 20249
4 202331
5 20233
6 20227
7 20223
8 202149
9 202124
10 202156
11
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Hit paper breakdown →
2020789
12 202045
13 201959
14 2015166
15 201323
16
Abstract 13026: Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial
20122
17 2010132
18 2006102
19 200518
20 199492

About Rafael Díaz

Rafael Díaz is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics, having authored 130 papers that have together received 18.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (28 papers), Acute Myocardial Infarction Research (27 papers), Antiplatelet Therapy and Cardiovascular Diseases (26 papers), Atrial Fibrillation Management and Outcomes (20 papers), Heart Failure Treatment and Management (17 papers), Cardiovascular Function and Risk Factors (16 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). The work is most often cited by research in Internal Medicine (4.1k citations), Cardiology and Cardiovascular Medicine (12.7k citations), Endocrinology, Diabetes and Metabolism (3.9k citations), Surgery (3.1k citations) and Hematology (745 citations). Rafael Díaz has collaborated with scholars based in Argentina, Canada and United States. Frequent co-authors include Salim Yusuf, John W. Eikelboom, Basil S. Lewis, Stuart J. Connolly, Denis Xavier, Jun Zhu, Marco Alings, Janice Pogue, Campbell Joyner and Lars Wallentin. Their work appears in journals such as Circulation, American Heart Journal, European Heart Journal, Journal of the American College of Cardiology and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026